Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma.

Hiroya Oka, Yuji Chatani, Rika Hoshino, +7

PubMed

Renal PathologyMapk CascadeCancer BiologyTumor BiologySignaling Pathway +16

Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine

Hatsuo Maeda, Seiji Hori, Hiroshi Ohizumi, +4

Cell Death and Differentiation

Surgical OncologyOncologyMedicineAdvanced Solid TumorsEffective Treatment +6

Mosaic and polymorphic imprinting of the WT1 gene in humans

Yoshihiro Jinno, Kankatsu Yun, Kunihiko Nishiwaki, +4

Nature Genetics

Developmental BiologyWt1 GeneGenetic DisorderGeneticsHuman Polymorphism +5

Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma.

Ryoji Morita, S. Saito, Jiro ISHIKAWA, +4

PubMed

CytogeneticsGeneticsRenal PathologyPathologyAllelic Losses +16

Constitutional relaxation of insulin–like growth factor II gene imprinting associated with Wilms' tumour and gigantism

Osamu Ogawa, D. M. O. Becroft, Ian M. Morison, +4

Nature Genetics

MedicineGeneticsNatural SciencesPathologyGene Expression +4

Overexpression of humanmutT homologue gene messenger RNA in renal-cell carcinoma: Evidence of persistent oxidative stress in cancer

Keisei Okamoto, Shinya Toyokuni, Wun‐Jae Kim, +5

International Journal of Cancer

Oncogene Amplification in Urothelial Cancers With p53 Gene Mutation or MDM2 Amplification

Tomonori Habuchi, Hiroshi Kinoshita, Hiroyuki Yamada, +6

JNCI Journal of the National Cancer Institute

Gene AmplificationMdm2 AmplificationUrologyOncologyOncogene Amplification +12

Androgen receptor CAG repeat length polymorphism in benign prostatic hyperplasia (BPH): Correlation with adenoma growth

Kenji Mitsumori, Akito Terai, Hiroya Oka, +4

The Prostate

Prospective Evaluation of Selection Criteria for Active Surveillance in Japanese Patients with Stage T1cN0M0 Prostate Cancer

Yoshiyuki Kakehi, Toshiyuki Kamoto, Tadashi Shiraishi, +25

Japanese Journal of Clinical Oncology

Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer.

Jean Lu, Yoshiyuki Kakehi, Toshiyuki Takahashi, +6

PubMed

Uroplakin IiTumor BiologyUrologyOncologyUp Ii +12